Actively Recruiting
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Led by Glaukos Corporation · Updated on 2024-07-08
150
Participants Needed
3
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.
CONDITIONS
Official Title
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide written informed consent
- Ability to hold gaze sufficiently stable for study testing
- Willingness and ability to follow all instructions and comply with schedule for follow-up visits
- Have a diagnosis of keratoconus
You will not qualify if you...
- Known allergy or sensitivity to the test articles or components
- Any disease causing abnormal topography other than keratoconus
- Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Glaukos Investigative Site
Dothan, Alabama, United States, 36301
Actively Recruiting
2
Glaukos Investigative Site
Teaneck, New Jersey, United States, 07666
Actively Recruiting
3
Glaukos Investigative Site
Westerville, Ohio, United States, 43082
Actively Recruiting
Research Team
M
Marco Armijo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here